Jubilant Life Sciences said on Wednesday its unit has signed a $70-million contract to manufacture an over-the-counter women’s healthcare product for a US-based company.
The product will be manufactured at its facility in Canada for a period of four years, it said in a statement.
The contract can be extended for another two years for a higher quantity, it said.
[caption id=“attachment_84091” align=“alignleft” width=“380” caption=“It will manufacture an over-the-counter women’s healthcare product for a US-based company.Photo: Flickr/Creative Commons”]
[/caption]
It did not name the US firm or give details of the product.
“This contract is an outcome of our strategy to expand offerings across products and geographies. We are happy to extend services for an over-the-counter product with a leading customer in North America,” Shyam Bhartia, chairman and managing director, Jubilant Life Sciences, said.
This is the second large deal for Jubilant in the last one month after it signed a $33 million manufacturing contract with a U.S. firm.
Reuters